GUBRF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Gubra A/S GUBRF'ün son çeyrekteki geliri nasıl performans gösterdi?
Gubra A/S'in gelir tahmini nedir?
Gubra A/S'in kazanç kalite puanı nedir?
Gubra A/S kazançlarını ne zaman rapor eder?
Gubra A/S'in beklenen kazançları nelerdir?
Gubra A/S kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$97.06
Açılış fiyatı
$98.16
Günün Aralığı
$60.15 - $60.15
52 haftalık aralık
$60.15 - $102.41
İşlem hacmi
700
Ort.Hacim
700
EPS (TTM)
--
Dividend yield
--
Piyasa Değeri
$983.4M
GUBRF nedir?
Gubra A/S engages in providing research and development services to pharmaceutical and biotechnology companies on a contract basis. The Company’s operations are anchored around its advanced technology platforms and utilization of automation, robotization and digitalization, including machine learning (ML) and artificial intelligence (AI). The firm's business activity are divided into two segments: The CRO Segment offers specialized profitable pre-clinical contract research services at attractive margins within metabolic and fibrotic disease areas such as diabetes, obesity, chronic kidney disease; and The Discovery and Partnership Segment is based on an internal target and drug discovery engine for identification and design of peptide-based drug partnering candidates within metabolic and fibrotic diseases.